Nintedanib 150 mg | Nintedone 150

Description

Nintedanib 150 mg NINTEDONE 150 is a pharmaceutical product that contains Nintedanib 150 mg, a potent antifibrotic agent used primarily in the treatment of progressive lung diseases. Nintedanib belongs to a class of medications known as tyrosine kinase inhibitors (TKIs). It is commonly prescribed for managing Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), and other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. Manufactured and marketed by Steris Healthcare, NINTEDONE 150 ensures consistent quality, affordability, and adherence to international manufacturing standards. What is Nintedanib 150 mg (NINTEDONE 150)? Nintedanib is an oral medication that works by blocking multiple receptor tyrosine kinases (RTKs) involved in the process of fibrosis (scarring). These include platelet-derived growth factor receptors (PDGFRs), fibroblast growth factor receptors (FGFRs), and vascular endothelial growth factor receptors (VEGFRs). By inhibiting these growth factors, NINTEDONE 150 slows down the progression of fibrosis, particularly in lung tissues. It does not cure the disease but helps preserve lung function and improves quality of life in patients suffering from fibrosing lung disorders. Uses of NINTEDONE 150 (Nintedanib 150 mg) NINTEDONE 150 is indicated for the treatment of: Idiopathic Pulmonary Fibrosis (IPF): A chronic, progressive lung disease characterized by scarring of lung tissue. Chronic Fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype. Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD): A rare autoimmune disorder affecting connective tissues and causing lung fibrosis. By targeting the cellular pathways involved in fibrosis, NINTEDONE 150 helps slow down lung tissue scarring, reduce lung function decline, and support better disease control. Side Effects of Nintedanib 150 mg While NINTEDONE 150 is generally well tolerated, patients may experience some side effects: Common Side Effects: Diarrhea (most common) Nausea and vomiting Abdominal pain Decreased appetite Headache Weight loss Liver enzyme elevation Serious Side Effects (rare but important): Liver toxicity Gastrointestinal bleeding Arterial thromboembolic events Hypertension Gastrointestinal perforation (rare) Patients are advised to report any unusual symptoms to their healthcare provider immediately and undergo regular liver function tests during treatment. Precautions Before Using NINTEDONE 150 Before starting NINTEDONE 150, it’s important to discuss the following with your healthcare provider: Liver Function: Pre-existing liver problems may increase the risk of liver toxicity. Dose adjustments may be required. Bleeding Risk: Use with caution in patients on blood thinners or with a history of bleeding disorders. Heart Disease: Monitor patients with a history of cardiovascular events closely. Pregnancy and Lactation: Nintedanib may cause fetal harm. Avoid use during pregnancy and breastfeeding. Surgery: Temporary discontinuation may be recommended before surgical procedures due to bleeding risk. Drug Interactions Certain medications may affect the way NINTEDONE 150 works or increase the risk of side effects. Always inform your doctor about all the medications and supplements you are taking. Notable interactions include: P-glycoprotein (P-gp) inhibitors/inducers: Such as ketoconazole, rifampicin Anticoagulants and antiplatelet agents Other TKIs or cytotoxic agents Avoid grapefruit or grapefruit juice as it may affect drug metabolism. Why Choose Steris Healthcare’s NINTEDONE 150? Steris Healthcare is committed to delivering advanced, reliable, and affordable pharmaceutical care for chronic diseases. When choosing NINTEDONE 150, you get: Clinically approved formulations Strict quality control and regulatory compliance Competitive pricing without compromising on efficacy Renal and pulmonary support specialists across the Steris network Consistent availability for chronic therapy needs With a focus on innovation and patient safety, Steris Healthcare stands as a trusted brand for specialty medicines in India and beyond. Conclusion NINTEDONE 150 (Nintedanib 150 mg) represents a powerful tool in the modern management of progressive interstitial lung diseases. It offers a proven, effective way to slow fibrosis, reduce lung damage, and support longer-term respiratory health. Combined with Steris Healthcare’s commitment to quality, affordability, and patient-first solutions, NINTEDONE 150 empowers patients to take control of their lung health — one breath at a time.